Open AccessCombination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis
Author(s) -
М С Фоминых,
Vasily Shuvaev,
Irina Martynkevich,
Л Б Полушкина,
В Ю Удальева,
К М Абдулкадыров
Publication year - 2016
Publication title -
onkogematologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.118
H-Index - 3
eISSN - 2413-4023
pISSN - 1818-8346
DOI - 10.17650/1818-8346-2016-11-2-37-39
Subject(s) - myelofibrosis , ruxolitinib , medicine , cytarabine , tolerability , combination therapy , oncology , chemotherapy , phases of clinical research , gastroenterology , adverse effect , bone marrow